Skip to main content

Table 1 Baseline characteristics after matching

From: Does smooth endoplasmic reticulum aggregation in oocytes impact the chromosome aneuploidy of the subsequent embryos? A propensity score matching study

 

Case (n = 113)

SERa(+) cycle

Control (n = 113)

SERa(-) cycle

P value

Age (years)

30 (28, 34)

30 (28, 33)

0.807

BMI (kg/m2)

21.5 (20.3, 23.5)

21.6 (19.5, 23.4)

0.353

FSH (IU/L)

6.7 (6.1, 8.4)

6.8 (5.9, 8.0)

0.506

AMH (ng/mL)

4.0 (2.5, 7.5)

4.3 (2.7, 7.5)

0.583

AFC

14 (9, 22)

15 (11, 20)

0.479

ART attempts

1 (1, 1)

1 (1, 1)

0.277

Infertility durations (years)

2.0 (0.0, 3.0)

1.5 (0.7, 3.0)

0.984

Infertility types

  

0.786

 Primary, %(n)

40.7 (46)

38.9 (44)

 

 Secondary, %(n)

59.3 (67)

61.1 (69)

 

COH protocols

  

0.905

 GnRH agonist protocol, %(n)

62.8 (71)

65.5 (74)

 

 GnRH antagonist protocol, %(n)

30.1 (34)

27.4 (31)

 

 Other protocola, %(n)

7.1 (8)

7.1 (8)

 

Gonadotropin dosage (IU)

2475 (1823, 3000)

2325 (1860, 2963)

0.946

Gonadotropin duration (days)

10 (9, 11)

10 (9, 12)

0.381

Estradiol on HCG day (pg/mL)

3000 (1756, 4386)

2417 (1635, 4435)

0.339

Progesterone on HCG day (ng/mL)

0.9 (0.6, 1.3)

0.9 (0.6, 1.3)

0.746

Endometrium thickness on HCG day (mm)

11.3 (9.0, 13.3)

10.6 (9.1, 12.7)

0.510

No. of large follicles

12 (9, 16)

12 (8, 16)

0.574

  1. BMI Body mass index, FSH Follicle stimulation hormone, AMH Anti-müllerian hormone, AFC Antral follicle counting, ART Assisted reproductive technology, COH Controlled ovarian hyperstimulation, GnRH Gonadotrophin releasing hormone, HCG Human chorionic gonadotropin
  2. aOther protocol: including mild stimulation and luteal phase stimulation protocols
  3. Continuous variables were presented as median (first quartile, third quartile)
  4. Categorical variables were presented as % (n)
  5. P < 0.05 was considered statistically significant